64 related articles for article (PubMed ID: 8386137)
1. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent.
Melkert PW; Hopman E; van den Brule AJ; Risse EK; van Diest PJ; Bleker OP; Helmerhorst T; Schipper ME; Meijer CJ; Walboomers JM
Int J Cancer; 1993 Apr; 53(6):919-23. PubMed ID: 8386137
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
Aleksioska-Papestiev I; Chibisheva V; Micevska M; Dimitrov G
Med Arch; 2018 Feb; 72(1):26-30. PubMed ID: 29416214
[TBL] [Abstract][Full Text] [Related]
3. The singular epidemiology of HPV infection among French Guianese women with normal cytology.
Adenis A; Dufit V; Douine M; Najioullah F; Molinie V; Catherine D; Kilié O; Thomas N; Deshayes JL; Brousse P; Amor HB; Pignoux R; Carles G; Grenier C; Lacoste V; Cesaire R; Nacher M
BMC Public Health; 2017 Mar; 17(1):279. PubMed ID: 28340612
[TBL] [Abstract][Full Text] [Related]
4. Induction of Bcl-2 expression by hepatitis B virus pre-S2 mutant large surface protein resistance to 5-fluorouracil treatment in Huh-7 cells.
Hung JH; Teng YN; Wang LH; Su IJ; Wang CC; Huang W; Lee KH; Lu KY; Wang LH
PLoS One; 2011; 6(12):e28977. PubMed ID: 22216150
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of viral infection and propagation: an overview of the second Advanced Summer School in Africa.
Green VA; Munshi SU; Marakalala MJ; Mourão MM
IUBMB Life; 2010 Aug; 62(8):573-83. PubMed ID: 20681023
[No Abstract] [Full Text] [Related]
6. Human papillomavirus infection in Honduran women with normal cytology.
Tábora N; Bakkers JM; Quint WG; Massuger LF; Matute JA; Melchers WJ; Ferrera A
Cancer Causes Control; 2009 Nov; 20(9):1663-70. PubMed ID: 19685147
[TBL] [Abstract][Full Text] [Related]
7. Comparison of GP5+/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia.
Hesselink AT; van Ham MA; Heideman DA; Groothuismink ZM; Rozendaal L; Berkhof J; van Kemenade FJ; Massuger LA; Melchers WJ; Meijer CJ; Snijders PJ
J Clin Microbiol; 2008 Oct; 46(10):3215-21. PubMed ID: 18685007
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of 34 human papillomavirus types in the German general population.
Michael KM; Waterboer T; Sehr P; Rother A; Reidel U; Boeing H; Bravo IG; Schlehofer J; Gärtner BC; Pawlita M
PLoS Pathog; 2008 Jun; 4(6):e1000091. PubMed ID: 18566657
[TBL] [Abstract][Full Text] [Related]
9. Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis.
Kulasingam SL; Benard S; Barnabas RV; Largeron N; Myers ER
Cost Eff Resour Alloc; 2008 Feb; 6():4. PubMed ID: 18279515
[TBL] [Abstract][Full Text] [Related]
10. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ
J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381
[TBL] [Abstract][Full Text] [Related]
11. Evaluating human papillomavirus vaccination programs.
Taira AV; Neukermans CP; Sanders GD
Emerg Infect Dis; 2004 Nov; 10(11):1915-23. PubMed ID: 15550200
[TBL] [Abstract][Full Text] [Related]
12. The predicted effect of changes in cervical screening practice in the UK: results from a modelling study.
Canfell K; Barnabas R; Patnick J; Beral V
Br J Cancer; 2004 Aug; 91(3):530-6. PubMed ID: 15266332
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme.
Sherlaw-Johnson C; Philips Z
Br J Cancer; 2004 Jul; 91(1):84-91. PubMed ID: 15162150
[TBL] [Abstract][Full Text] [Related]
14. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population.
Cuschieri KS; Cubie HA; Whitley MW; Seagar AL; Arends MJ; Moore C; Gilkisson G; McGoogan E
J Clin Pathol; 2004 Jan; 57(1):68-72. PubMed ID: 14693839
[TBL] [Abstract][Full Text] [Related]
15. Extended duration of the detectable stage by adding HPV test in cervical cancer screening.
van den Akker-van Marie ME; van Ballegooijen M; Rozendaal L; Meijer CJ; Habbema JD
Br J Cancer; 2003 Nov; 89(10):1830-3. PubMed ID: 14612887
[TBL] [Abstract][Full Text] [Related]
16. Prospective study on cervical neoplasia: presence of HPV DNA in cytological smears precedes the development of cervical neoplastic lesions.
Tachezy R; Saláková M; Hamsíková E; Kanka J; Havránková A; Vonka V
Sex Transm Infect; 2003 Jun; 79(3):191-6. PubMed ID: 12794200
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus infection and use of oral contraceptives.
Green J; Berrington de Gonzalez A; Smith JS; Franceschi S; Appleby P; Plummer M; Beral V
Br J Cancer; 2003 Jun; 88(11):1713-20. PubMed ID: 12771986
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic.
Svare EI; Kjaer SK; Worm AM; Osterlind A; Meijer CJ; van den Brule AJ
Sex Transm Infect; 2002 Jun; 78(3):215-8. PubMed ID: 12238658
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and determinants of HPV infection among Colombian women with normal cytology.
Molano M; Posso H; Weiderpass E; van den Brule AJ; Ronderos M; Franceschi S; Meijer CJ; Arslan A; Munoz N;
Br J Cancer; 2002 Jul; 87(3):324-33. PubMed ID: 12177803
[TBL] [Abstract][Full Text] [Related]
20. Fluctuations in prevalence of cervical human papillomavirus in women frequently sampled during a single menstrual cycle.
van Ham MA; Melchers WJ; Hanselaar AG; Bekkers RL; Boonstra H; Massuger LF
Br J Cancer; 2002 Aug; 87(4):373-6. PubMed ID: 12177771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
